TargetMol

Tyloxapol

Product Code:
 
TAR-T0307
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0307-200mg200mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0307-500mg500mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0307-1g1g£113.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tyloxapol is a non-ionic liquid polymer used as a surfactant.
CAS:
25301-02-4
Formula:
C70H124O13
Molecular Weight:
137.18
Pathway:
GPCR/G Protein; NF-κb
Purity:
N/A
SMILES:
NCCC1=CC=C(O)C=C1
Target:
NF-κB; LPL Receptor

References

1. Rasouli M, et al. J Clin Diagn Res. 2016, 10(6):BF01-5. 2. Zheng J, et al. Chem Pharm Bull (Tokyo). 2010, 58(12):1612-1616. 3. Kristl J, et al. Toxicol Appl Pharmacol. 2008, 232(2):218-225. 4. Guo, Wen, et al. Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-?B and MAPK activation. Journal of Orthopaedic Translation . 28 (2021): 148-158.